Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by Ricky55on Jan 10, 2014 1:24pm
134 Views
Post# 22078799

Analysts & Gold price 2014

Analysts & Gold price 2014We have to be carefull about analysts.So many here in Stockhouse were talking about $3,000 onces target and i saw an article talking about $10,000 onces..........in 2012---2013.
What happen: Gold drop at $1,200.  Where are they now?What they have to say now?Except to explain what reasons why it did so!
Now,many banks and analysts are saying since august 2013 price of gold will drop at around $1,000 . Ok but look what happen: My NOX almost triple and Ovana ORV is about to double.
Could you imagine how poor i would be if i have listen to thoses guys...........
Doing the contrary against the analyst and the majority is sometimes rewarding.(At least in my cases-Nox and Orv)
Of course,someone have to use his common sense.Some analysts,a few,would give the right advise to follow but,even there,they will tell theirs customers before telling you.

<< Previous
Bullboard Posts
Next >>